Diagnosis of prostate cancer using differentially expressed genes in stroma
about
Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changesAn accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into accountMiniaturized pre-clinical cancer models as research and diagnostic tools.Minireview: the molecular and genomic basis for prostate cancer health disparitiesZinc transporters in prostate cancer.Coexpression and expression quantitative trait loci analyses of the angiogenesis gene-gene interaction network in prostate cancer.Role of the adjacent stroma cells in prostate cancer development and progression: synergy between TGF-β and IGF signaling.Integrative analysis reveals disease-associated genes and biomarkers for prostate cancer progression.Expression changes in the stroma of prostate cancer predict subsequent relapseEarly growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancerKey regulators in prostate cancer identified by co-expression module analysisDevelopment of a nuclear morphometric signature for prostate cancer risk in negative biopsies.A Balanced Tissue Composition Reveals New Metabolic and Gene Expression Markers in Prostate CancerArizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in China.A cross-cancer differential co-expression network reveals microRNA-regulated oncogenic functional modulesDigSee: Disease gene search engine with evidence sentences (version cancer).Asporin is a stromally expressed marker associated with prostate cancer progressionSenescent remodeling of the innate and adaptive immune system in the elderly men with prostate cancer.Reprogramming of prostate cancer cells--technical challenges.Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases.Generation of "virtual" control groups for single arm prostate cancer adjuvant trials.The identification of trans-associations between prostate cancer GWAS SNPs and RNA expression differences in tumor-adjacent stroma.A predictive role for noncancerous prostate cells: low connexin-26 expression in radical prostatectomy tissues predicts metastasisIntegrative genomic analysis for the discovery of biomarkers in prostate cancer.Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.A preclinical xenograft model of prostate cancer using human tumors.SFRP4 gene expression is increased in aggressive prostate cancer.
P2860
Q28292423-2076D458-1190-4599-BCE8-F56C86E61C9EQ28484126-907E4441-7DA3-4A91-905A-32C1C09B243DQ33605145-EB2ECAFE-C3FA-4F76-8880-D418756CAD58Q33633160-53CB8B67-E750-467A-A6C2-3E4436DBAE91Q33715474-880252D2-78AC-4F43-AFC4-54F3A4A45903Q33838280-1CA03C4B-B19C-472F-A654-D2132BFA2452Q33892994-E0472F3C-8639-44B1-ACA7-F960E9EA3FC2Q33948926-B61238DA-FA87-4922-AAC0-0771C8422218Q34368873-C9BD0A64-6C4E-4BC6-B132-5099A917C2BBQ34559139-9B7920AF-A158-4A90-BF96-0BBD273464A3Q34645685-D3FA2833-CC1B-4B83-865D-DDD44852896FQ34902668-1AF6F084-1CDA-4543-A79F-13857321979BQ35996026-013BEBA9-D80B-4197-A822-DC77E7A39D4AQ36121377-26757144-A95D-495A-B07C-DBB4CDDA7EC9Q36140962-D2009262-6775-4D99-B4ED-B5893E3524EBQ36275831-A2135485-C227-401D-ABB2-808E85A4ADBCQ36954045-6994D588-D8DA-4D3B-85D0-A3BCA8B0B982Q37707965-DC545575-73A6-4CB7-BA42-1B64C7DADBDAQ38207592-0D57D24D-AE33-43EF-90FC-696BFD6212F8Q38268944-FF5495CA-ED2B-4B72-81B2-F4D975AC14A0Q39341456-4216E170-B056-4FCD-B5B2-EB3CFFF6A9C1Q41882322-9566DD03-5D25-45F1-8E99-B6EA25EEC78EQ42102286-19330622-453F-4051-884B-7AA1F3A006C7Q42395864-2DDA28C3-E423-432E-B42E-F1187498B5E5Q42723558-34AE7F0E-7B7B-4F43-8A56-69DF2A19E26CQ42775329-C092AAAD-40E2-4450-A1BA-140EE96E51C4Q43880974-B922F13D-F6FE-4849-A207-55ED3D6C6D05Q45723424-727F1212-F4D0-4931-8D07-D937B06A9FF3
P2860
Diagnosis of prostate cancer using differentially expressed genes in stroma
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Diagnosis of prostate cancer using differentially expressed genes in stroma
@ast
Diagnosis of prostate cancer using differentially expressed genes in stroma
@en
Diagnosis of prostate cancer using differentially expressed genes in stroma
@nl
type
label
Diagnosis of prostate cancer using differentially expressed genes in stroma
@ast
Diagnosis of prostate cancer using differentially expressed genes in stroma
@en
Diagnosis of prostate cancer using differentially expressed genes in stroma
@nl
prefLabel
Diagnosis of prostate cancer using differentially expressed genes in stroma
@ast
Diagnosis of prostate cancer using differentially expressed genes in stroma
@en
Diagnosis of prostate cancer using differentially expressed genes in stroma
@nl
P2093
P2860
P50
P1433
P1476
Diagnosis of prostate cancer using differentially expressed genes in stroma
@en
P2093
Anne Sawyers
Anne Simoneau
Dan Mercola
Farahnaz Rahmatpanah
Frank Meyskens
Huazhen Yao
James A Koziol
Joseph Monforte
Manuel Sutton
Philip Carpenter
P2860
P304
P356
10.1158/0008-5472.CAN-10-2585
P407
P577
2011-04-01T00:00:00Z